Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
120.79
+0.18 (+0.15%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Meet the Unstoppable Vanguard ETF Beating the S&P 500 and the Dow Jones in 2026
↗
November 06, 2026
Small-cap stocks have benefited from a range of tailwinds this year.
Via
The Motley Fool
Topics
ETFs
Economy
Stocks
Why the Next Edge in Antibody Discovery May Be What Labs Remember
November 04, 2026
News Provided by Wall Street Investor on behalf of MindWalk Holdings Corp.
From
Wall Street Investor
Via
GlobeNewswire
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
November 03, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience TWST Q2 Fiscal 2026: Revenue Beat Offset by Wider EPS Miss
↗
May 04, 2026
Via
Chartmill
Twist Bioscience Launches MRD Express with Rapid Turnaround Time
October 29, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
October 28, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026
October 26, 2026
From
Twist Bioscience Corporation
Via
Business Wire
These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys?
↗
October 12, 2026
Forget the "Magnificent Seven" in favor of the "Tremendous Three"?
Via
The Motley Fool
Why Twist Bioscience Stock Skyrocketed This Week
↗
September 18, 2026
It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company.
Via
The Motley Fool
Topics
Artificial Intelligence
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
September 16, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
September 09, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
August 19, 2026
Via
Chartmill
Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript
↗
August 10, 2026
AI-enabled drug discovery orders drive triple-digit growth as guidance rises.
Via
The Motley Fool
Topics
Earnings
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
August 04, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
August 04, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 04, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Sees AI Drug Discovery Pipeline Expand
↗
August 03, 2026
Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discovery and NGS businesses show growth.
Via
Benzinga
Topics
Artificial Intelligence
Twist Bioscience Q3 Earnings Call Highlights
↗
August 03, 2026
Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 third-quarter revenue of $118.4 million, up 23% from a year earlier, marking its 14th consecutive quarter of growth. The company raised its full-year...
Via
MarketBeat
Topics
Earnings
Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
August 03, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy?
↗
July 19, 2026
Wood's ETFs sell stocks that have had strong runs to pay for other positions.
Via
The Motley Fool
Topics
ETFs
Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026
July 15, 2026
From
Twist Bioscience Corporation
Via
Business Wire
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own
↗
June 19, 2026
AI's next winners in healthcare could be companies like Eli Lilly and Twist Bioscience.
Via
The Motley Fool
Topics
Artificial Intelligence
Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.
↗
June 12, 2026
This synthetic DNA specialist, leveraging silicon chip technology, reported a notable insider sale amid a year of strong share gains.
Via
The Motley Fool
Topics
Regulatory Compliance
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
↗
June 06, 2026
This synthetic biology innovator, known for its DNA-based solutions, reported a notable insider sale amid a year of strong share gains.
Via
The Motley Fool
Topics
Regulatory Compliance
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million
↗
June 04, 2026
This synthetic biology firm, known for silicon-based DNA synthesis, reported a notable insider sale following strong one-year share gains.
Via
The Motley Fool
Topics
Regulatory Compliance
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
May 27, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 05, 2026
From
Twist Bioscience Corporation
Via
Business Wire
Twist (TWST) Q2 2026 Earnings Call Transcript
↗
May 04, 2026
Twist (TWST) Q2 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
Twist (TWST) Q3 2025 Earnings Transcript
↗
May 04, 2026
Twist (TWST) Q3 2025 Earnings Transcript
Via
The Motley Fool
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
May 04, 2026
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today